Glutathione, cysteine, and ascorbate concentrations in clinically ill dogs and cats

Journal of Veterinary Internal Medicine

Volumn 23, Issue 2, 2009, Pages 250-257

  Viviano, K R ^a   Lavergne, S N ^a   Goodman, L ^a   VanderWielen, B ^a   Grundahl, L ^a   Padilla, M ^a   Trepanier, L A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Antioxidants; Ascorbate; Cysteine; Glutathione; Oxidative stress

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

ASCORBIC ACID; CYSTEINE; GLUTATHIONE;

ANIMAL; ARTICLE; BLOOD; CASE CONTROL STUDY; CAT; CAT DISEASE; DOG; DOG DISEASE; ERYTHROCYTE; FEMALE; MALE; METABOLISM; NONPARAMETRIC TEST; OXIDATIVE STRESS; PHYSIOLOGY; PROSPECTIVE STUDY;

ANIMALS; ASCORBIC ACID; CASE-CONTROL STUDIES; CAT DISEASES; CATS; CYSTEINE; DOG DISEASES; DOGS; ERYTHROCYTES; FEMALE; GLUTATHIONE; MALE; OXIDATIVE STRESS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 66149146651     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0238.x     Document Type: Article

References (51)

1. Cowley HC, Bacon PJ, Goode HF, et al. Plasma antioxidant potential in severe sepsis: A comparison of survivors and nonsurvivors. Crit Care Med 1996;24:1179-1183.
2. Roth E, Manhart N, Wessner B. Assessing the antioxidative status in critically ill patients. Curr Opin Clin Nutr Metab Care 2004;7:161-168.
3. Nathens AB, Neff MJ, Jurkovich GJ, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002;236:814-822.
4. Alonso de Vega JM, Diaz J, Serrano E, et al. Plasma redox status relates to severity in critically ill patients. Crit Care Med 2000;28:1812-1814.
5. Borrelli E, Roux-Lombard P, Grau GE, et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996;24:392-397.
6. Goode HF, Cowley HC, Walker BE, et al. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995;23: 646-651.
7. Leff JA, Parsons PE, Day CE, et al. Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet 1993;341:777-780.
8. Jones DP. Redox potential of GSH/GSSG couple: Assay and biological significance. Methods Enzymol 2002;348:93-112.
9. Dominguez C, Ruiz E, Gussinye M, et al. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 1998;21:1736-1742.
10. Kretzschmar M, Pfeiffer L, Schmidt C, et al. Plasma levels of glutathione, alpha-tocopherol and lipid peroxides in polytraumatized patients; evidence for a stimulating effect of TNF alpha on glutathione synthesis. Exp Toxicol Pathol 1998;50:477-483.
11. Ong-awyooth L, Ong-ajyooth S, Tiensong K, et al. Reduced free radical scavengers and chronic renal failure. J Med Assoc Thai 1997;80:101-108.
12. Willcox JK, Ash SL, Catignani GL. Antioxidants and prevention of chronic disease. Crit Rev Food Sci Nutr 2004;44:275-295.
13. Trepanier LA, Yoder AR, Bajad S, et al. Plasma ascorbate deficiency is associated with impaired reduction of sulfamethoxaz-ole-nitroso in HIV infection. J Acquir Immune Defic Syndr 2004;36:1041-1050.
14. Lyons J, Rauh-Pfeiffer A, Ming-Yu Y, et al. Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients. Crit Care Med 2001;29:870-877.
15. Loguercio C, Del Vecchio Blanco F, Nastasi A, et al. Can dietary intake influence plasma levels of amino acids in liver cirrhosis? Dig Liver Dis 2000;32:611-616.
16. Rahman SH, Ibrahim K, Larvin M, et al. Association of antioxidant enzyme gene polymorphisms and glutathione status with severe acute pancreatitis. Gastroenterology 2004;126:1312-1322.
17. Dickinson DA, Forman HJ. Glutathione in defense and signaling: Lessons from a small thiol. Ann NY Acad Sci 2002;973:488-504.
18. Naisbitt DJ, Vilar FJ, Stalford AC, et al. Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection. AIDS Res Hum Retroviruses 2000;16:1929-1938.
19. White CW, Stabler SP, Allen RH, et al. Plasma cysteine concentrations in infants with respiratory distress. J Pediatr 1994;125: 769-777.
20. Ramakrishna BS, Varghese R, Jayakumar S, et al. Circulating antioxidants in ulcerative colitis and their relationship to disease severity and activity. J Gastroenterol Hepatol 1997;12:490-494.
21. Packer JE, Slater TF, Willson RL. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979;278:737-738.
22. Metnitz PG, Bartens C, Fischer M, et al. Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med 1999;25:180-185.
23. Memisogullari R, Taysi S, Bakan E, et al. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 2003;21:291-296.
24. Bonham MJ, Abu-Zidan FM, Simovic MO, et al. Early ascorbic acid depletion is related to the severity of acute pancreatitis. Br J Surg 1999;86:1296-1301.
25. Schorah CJ, Downing C, Piripitsi A, et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr 1996;63:760-765.
26. Freeman LM, Rush JE, Milbury PE, et al. Antioxidant status and biomarkers of oxidative stress in dogs with congestive heart failure. J Vet Intern Med 2005;19:537-541.
27. Wallace KP, Center SA, Hickford FH, et al. S-adenosyl-L-methionine (SAMe) for the treatment of acetaminophen toxicity in a dog. J Am Anim Hosp Assoc 2002;38:246-254.
28. Center SA, Warner KL, Erb HN. Liver glutathione concentrations in dogs and cats with naturally occurring liver disease. Am J Vet Res 2002;63:1187-1197.
29. Spee B, Mandigers PJ, Arends B, et al. Differential expression of copper-associated and oxidative stress related proteins in a new variant of copper toxicosis in Doberman Pinschers. Comp Hepatol 2005;4:3.
30. Freeman LM, Brown DJ, Rush JE. Antioxidant status in dogs with idiopathic dilated cardiomyopathy. J Nutr 1998;128: 2768S-2770S.
31. Hinchcliff KW, Reinhart GA, DiSilvestro R, et al. Oxidant stress in sled dogs subjected to repetitive endurance exercise. Am J Vet Res 2000;61:512-517.
32. Lang CA, Mills BJ, Mastropaolo W, et al. Blood glutathione decreases in chronic diseases. J Lab Clin Med 2000;135:402-405.
33. Reid M, Badaloo A, Forrester T, et al. In vivo rates of erythrocyte glutathione synthesis in children with severe protein-energy malnutrition. Am J Physiol Endocrinol Metab 2000;278:E405-E412.
34. Jahoor F, Wykes LJ, Reeds PJ, et al. Protein-deficient pigs cannot maintain reduced glutathione homeostasis when subjected to the stress of inflammation. J Nutr 1995;125:1462-1472.
35. Robinson MK, Rounds JD, Hong RW, et al. Glutathione deficiency increases organ dysfunction after hemorrhagic shock. Surgery 1992;112:140-147, discussion 148-149.
36. Allison RW, Lassen ED, Burkhard MJ, et al. Effect of a bioflavonoid dietary supplement on acetaminophen-induced oxidative injury to feline erythrocytes. J Am Vet Med Assoc 2000;217: 1157-1161.
37. Webb CB, Twedt DC, Fettman MJ, et al. S-adenosylmethionine (SAMe) in a feline acetaminophen model of oxidative injury. J Feline Med Surg 2003;5:69-75.
38. Webb C, Bedwell C, Guth A, et al. Use of flow cytometry and monochlorobimane to quantitate intracellular glutathione con- centrations in feline leukocytes. Vet Immunol Immunopathol 2006;112:129-140.
39. Hirano H, Tone Y, Otani H, et al. Levels of serum ascorbate and its metabolites in hemodialysis patients. Nippon Jinzo Gakkai Shi 2004;46:426-433.
40. Burns JJ, Mosbach EH, Schulenberg S. Ascorbic acid synthesis in normal and drug-treated rats, studied with L-ascorbic- 1-C14 acid. J Biol Chem 1954;207:679-687.
41. Linster CL, Van Schaftingen E. Rapid stimulation of free glucuronate formation by non-glucuronidable xenobiotics in isolated rat hepatocytes. J Biol Chem 2003;278:36328-36333.
42. Martensson J, Meister A. Glutathione deficiency increases hepatic ascorbic acid synthesis in adult mice. Proc Natl Acad Sci USA 1992;89:11566-11568.
43. Harvey JW, Kaneko JJ. Mammalian erythrocyte metabolism and oxidant drugs. Toxicol Appl Pharmacol 1977;42:253-261.
44. Ciriolo MR, Palamara AT, Incerpi S, et al. Loss of GSH, oxidative stress, and decrease of intracellular pH as sequential steps in viral infection. J Biol Chem 1997;272:2700-2708.
45. Staal FJ, Ela SW, Roederer M, et al. Glutathione deficiency and human immunodeficiency virus infection. Lancet 1992;339: 909-912.
46. Sbrana E, Paladini A, Bramanti E, et al. Quantitation of reduced glutathione and cysteine in human immunodeficiency virus-infected patients. Electrophoresis 2004;25:1522-1529.
47. Herzenberg LA, De Rosa SC, Dubs JG, et al. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci USA 1997;94:1967-1972.
48. Giustarini D, Milzani A, Dalle-Donne I, et al. Red blood cells as a physiological source of glutathione for extracellular fluids. Blood Cells Mol Dis 2008;40:174-179.
49. De AK, Darad R. Age-associated changes in antioxidants and antioxidative enzymes in rats. Mech Ageing Dev 1991;59:123-128.
50. Center SA, Randolph JF, Warner KL, et al. The effects of S-adenosylmethionine on clinical pathology and redox potential in the red blood cell, liver, and bile of clinically normal cats. J Vet Intern Med 2005;19:303-314.
51. Torres CL, Miller JW, Rogers QR. Determination of free and total cyst(e)ine in plasma of dogs and cats. Vet Clin Pathol 2004;33:228-233.